US Regulator Warns Sri Krishna Pharma, Citing Drug-Data Manipulation

Mumbai: Sri Krishna Pharmaceuticals, a supplier of paracetamol and other drugs to more than 60 countries, has been warned by the US Food and Drug Administration (FDA), which cited manipulation of its test results at a plant. The company, based in Hyderabad, is the latest drug maker in the country to get such a warning. Similar data-integrity issues found by the FDA at other Indian drug firms have led to dozens of manufacturing plant...